Carl A Gregory
Overview
Explore the profile of Carl A Gregory including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
2656
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haskell A, Pan S, Reese R, Powers A, Lopez M, Lomeli S, et al.
Sci Rep
. 2025 Mar;
15(1):7638.
PMID: 40038476
No abstract available.
2.
Haskell A, Pan S, Reese R, Powers A, Lopez M, Lomeli S, et al.
Sci Rep
. 2025 Jan;
15(1):1878.
PMID: 39805917
Osteosarcoma (OS) is the most common primary bone malignancy. The canonical Wnt inhibitor Dickkopf-1 (Dkk-1) has been implicated in bone destruction, tumor survival and metastases during OS. We examined the...
3.
Shape Memory Polymer Scaffolds-Utility for In Vitro Osteogenesis of Canine Multipotent Stromal Cells
Gasson S, Dobson L, Pfau-Cloud M, Beltran F, Gregory C, Grunlan M, et al.
J Biomed Mater Res B Appl Biomater
. 2024 Nov;
112(12):e35503.
PMID: 39587932
A biodegradable, shape memory polymer (SMP) scaffold based on poly(ε-caprolactone) (PCL) represents an attractive alternative therapy for the repair of critically sized bone defects given its ability to press-fit within...
4.
Gasson S, Dobson L, Pfau-Cloud M, Beltran F, Pool R, Gregory C, et al.
J Biomed Mater Res A
. 2024 Oct;
113(1):e37806.
PMID: 39404147
Biodegradable, shape memory polymer (SMP) scaffolds based on poly(ε-caprolactone) (PCL) offer unique advantages as a regenerative treatment strategy for critical-sized bone defects. In particular, a conformal fit may be achieved...
5.
Recalde Phillips S, Perez-Ponce K, Ruben E, Baig T, Poux E, Gregory C, et al.
Biomacromolecules
. 2024 Aug;
25(9):5798-5808.
PMID: 39190621
Microporous annealed particle (MAP) hydrogels are a promising class of in situ-forming scaffolds for tissue repair and regeneration. While an expansive toolkit of annealing chemistries has been described, the effects...
6.
Benavides O, White B, Gibbs H, Kaunas R, Gregory C, Maitland K, et al.
J Biomed Opt
. 2024 Jun;
29(Suppl 2):S22708.
PMID: 38872791
Significance: The ability to observe and monitor cell density and morphology has been imperative for assessing the health of a cell culture and for producing high quality, high yield cell...
7.
Gregory C, Ma J, Lomeli S
Front Mol Biosci
. 2024 Apr;
11:1376091.
PMID: 38606288
Collagen VI and collagen XII are structurally complex collagens of the extracellular matrix (ECM). Like all collagens, type VI and XII both possess triple-helical components that facilitate participation in the...
8.
Haskell A, White B, Rogers R, Goebel E, Lopez M, Syvyk A, et al.
Cytotherapy
. 2024 Feb;
26(4):372-382.
PMID: 38363250
Background Aims: Human mesenchymal stromal cells (hMSCs) and their secreted products show great promise for treatment of musculoskeletal injury and inflammatory or immune diseases. However, the path to clinical utilization...
9.
Xin S, Dai J, Gregory C, Han A, Alge D
Adv Funct Mater
. 2024 Jan;
30(6).
PMID: 38213754
Microporous annealed particle (MAP) hydrogels are an attractive platform for engineering biomaterials with controlled heterogeneity. Here, we introduce a microfluidic method to create physicochemical gradients within poly(ethylene glycol) based MAP...
10.
Lee R, Boregowda S, Shigemoto-Kuroda T, Bae E, Haga C, Abbery C, et al.
Sci Adv
. 2023 Nov;
9(45):eadi2387.
PMID: 37948519
Mesenchymal stem/stromal cells (MSCs) have been evaluated in >1500 clinical trials, but outcomes remain suboptimal because of knowledge gaps in quality attributes that confer potency. We show that TWIST1 directly...